Below is a news feature describing the recent developments and the innovative landscape of the **Boao Lecheng International Medical Tourism Pilot Zone** in Hainan, written in English.

---

## Hope City: Hainan’s Boao Lecheng Redefines Global Healthcare Access

**BOAO, HAINAN** — In the lush tropical landscape of southern China, a medical revolution is quietly reaching its zenith. The **Boao Lecheng International Medical Tourism Pilot Zone**, affectionately known as "Hope City," has transitioned from a localized experiment into a global powerhouse for healthcare innovation and medical tourism.

### A Gateway for Global Innovation

As of early 2026, Boao Lecheng has shattered regulatory records. While the standard pathway for overseas innovative drugs to enter the Chinese market typically takes three to eight years, Lecheng has leveraged its "special zone" status to slash approval timelines. Recently, the average approval time for globally advanced medical products in the zone was reported to be as low as **1.6 days**.

By the second quarter of 2026, the zone has successfully introduced over **550 innovative drugs and medical devices** that are approved by the US FDA or European EMA but are not yet available in the rest of mainland China.

[Image of the Boao Lecheng International Medical Tourism Pilot Zone aerial view]

### Breaking Boundaries in Treatment

Lecheng is no longer just for domestic patients. Following the launch of island-wide special customs operations in the Hainan Free Trade Port (FTP) and the implementation of a **59-country, 30-day visa-free entry policy**, the zone has seen a surge in international patients from countries such as Vietnam, Greece, and South Korea.

Key highlights of the zone's 2026 milestones include:

* **Real-World Evidence (RWE) Success:** By leveraging clinical data collected from patients in the zone, 21 international innovative drugs have been fast-tracked for full Chinese market approval, with several already integrated into the national medical insurance system.

* **Cutting-Edge Technology:** The zone recently launched the "Super AI Hospital," a platform providing AI-assisted imaging and remote consultations. It also celebrated the first Chinese clinical application of Korean cell therapies and breakthrough brain-machine interface (BCI) devices.

* **Medical Tourism Expansion:** Beyond surgery and oncology, the zone now offers **35 specialized medical tourism routes**, combining high-end health screenings and chronic disease management with Hainan’s world-class resort environment.

### A Magnet for Global Investment

The pilot zone has established deep-rooted partnerships with more than **180 pharmaceutical and medical device companies** from over 20 countries, including giants like Pfizer, AstraZeneca, and Roche. With a zero-tariff policy on imported medical equipment and the rise of local production bases scheduled for operation by the end of 2026, Lecheng is evolving from a "window of treatment" into a "hub of industry."

> "Lecheng is a testament to what targeted opening-up can achieve," says a local health official. "We aren't just importing drugs; we are importing hope and exporting a new model for the future of global healthcare."

---

### Key Statistics (April 2026)

| Metric | Current Status |

| :--- | :--- |

| **Licensed Drugs/Devices** | 550+ |

| **Global Partners** | 180+ Companies |

| **Patient Reach** | 200,000+ benefited |

| **Visa-Free Access** | 59 Countries |

| **Avg. Approval Speed** | 1.6 Days |